Valuation check: MTD's profit margin is 21.4%, above the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
The latest profit margin for MTD is 21.4% as of March 2026. That compares with 22.17% in the prior-year period — down 3.5% year over year. That is above the Healthcare sector average of 15.58%. Investors often review this figure alongside Mettler-Toledo International's historical trend and sector peers before judging valuation or financial health.
Over the past year, MTD's profit margin moved from 22.17% to 21.4% — a 3.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Mettler-Toledo International's valuation or profitability profile.
Against Healthcare companies, MTD currently prints 21.4% for profit margin, while the sector average sits near 15.58%. That is roughly 37.3% above the sector mean. Large gaps often invite a closer look at Mettler-Toledo International's growth, margins, and balance sheet.
Profit Margin shows how effectively Mettler-Toledo International converts resources into returns. At 21.4%, MTD may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 22.17% in the prior-year period — down 3.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting MTD's profit margin (21.4%), review year-over-year change from 22.17%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.